ISOLATED CEREBRAL ARTERIES of human 1 2 and other species 2 ' 3 contract in the presence of adrenergic agonists, in a dose dependent manner. When the contraction is blocked by alpha adrenergic antagonists, isoproterenol induces relaxation, in a dose dependent manner in human, 1 -4 cat, 3 and dog 4 cerebral arteries. This relaxation was blocked by propranolol. These data suggested the existence of not only alpha adrenergic receptors but also beta adrenergic receptors in the cerebral arteries. Beta adrenergic receptors have been classified into beta 1 and beta 2, according to affinity Pharmacological studies suggested that beta 1 adrenergic receptors mediated relaxations in human 1 and cat 3 cerebral arteries, whereas in other peripheral vessels, beta 2 adrenergic receptors seemed to mediate relaxations. 6 It was reported that blood flow in the caudate nucleus of rabbit brain was increased by isoproterenol and that the increase was blocked by a selective beta 1 adrenergic antagonist, practolol 7 On the contrary, biochemical studies suggested the predominant existence of beta 2 adrenergic receptors in the cat cerebral microvessels.' Thus subtypes of beta adrenergic receptors on the cerebral arteries were not clearly characterized.
Vasospasm of cerebral arteries in the case of subarachnoid hemorrhage (SAH) frequently presents severe clinical problems, as a result of cerebral ischemia. The pathogenesis of vasospasm is still poorly understood. The level of circulatory catecholamines often increases after SAH. 9 ' l0 In addition, the contractile response of human cerebral arteries to norepinephrine is larger than the responses in other species.
2 ' " Thus, neurogenic factors in controlling brain circulation would play an important role in pathological conditions such as SAH. We reported evidence of alteration of alpha adrenergic receptors after SAH. 12 In this study, beta adrenergic receptors in human cerebral arteries were characterized using 3 H-dihydroalprenolol (DHA), and alterations in these receptors after SAH were analyzed.
Materials and Methods Collection of Arteries
Cerebral arteries (mainly basilar, circle of Willis and middle cerebral arteries) were carefully removed at autopsy between 1 and 2 hours after death. These arteries were then washed in saline and placed in a freezer ( -80 °C). Clinical profiles of patients are summarized in table 1.
Membrane Preparation
Membrane was prepared as described in the previous report. 12 The arteries were minced with scissors and homogenized in 10 volumes of ice-cold 50 mM sodium phosphate buffer (pH 7.4) with a glass homogenizer. The homogenates were filtered through two layers of gauze, re-homogenized at setting 10 on a Polytron with 20s burst, centrifuged at 1,000 X g for 10 min and supernatant carefully removed and centrifuged at 100,000 x g for 60 min. The resulting pellet was resuspended in 50 mM sodium phosphate buffer (pH 7.4). Protein concentration was determined by the method of Lowry et al.
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Binding Assay 3 H-DHA bindings were performed by incubating aliquots of the cerebral artery homogenates at a temperature of 37 °C for 30 min in 250 yA of sodium phosphate buffer, containing 3 H-DHA, in the absence or presence of high concentrations of propranolol (10 iM) . The binding in the presence of 10 /i,M propranolol was termed "nonspecific" and was subtracted from that obtained in the absence of propranolol "total binding" to obtain the binding termed "specific binding". The assay was terminated by the addition of 3 ml of the ice-cold buffer and the rapid filtration through Whatman GF/B glass fiber filters, under suction. After washing twice with 3 ml of the buffer, the filters were dried in an oven, transferred to counting vials and 8 ml of scintillation fluid was added. Radioactivity was counted in a Packard Tri-Carb scintillation spectrometer (Model 3255).
To obtain the displacement curve, homogenates of the artery were added to the tubes containing the beta adrenergic agents at various concentrations, and 15 nM 3 H-DHA.
Drugs Used 3 H-DHA (specific activity, 34.1 Ci/mmoles) was purchased from New England Nuclear, Boston, MA, USA, stored at -20°C in ethanol and protected from light. Immediately prior to use, appropriate amounts of stock solutions were diluted with distilled water so that the ethanol concentrations in the final assay system did not exceed 0.5%. Acebutolol (May & Baker, England), butoxamine (Burroughs Wellcome Co., USA), Metoprolol (AB Hassle, Sweden) and Salbutamol (Schering, USA) were obtained from the manufacturers. All other chemicals were of reagent grade or of the purest grade commercially available.
Computer Analysis of the Data
Scatchard analysis was performed according to Bennet.
14 Hofstee plots were curvilinear, suggesting the presence of multiple binding sites. Data on bindings were analyzed by a nonlinear best-squared fit of the amount of specific 3 H-DHA binding, as a function of the free 3 H-DHA in the assay, using a FUJITSU MICRO 7 computer. Data points were fitted to a twoindependent binding site model (Eq. 1) described by Olsen et al. figure 3 . Among agonists, isoproterenol was most potent with Ki of 1.7 x 10^M and nH of 0.8. The order of potency isoproterenol > epinephrine > norepinephrine is consistent with the stimulation of beta adrenergic receptors containing beta 2 subtype. 5 Salbutamol, 16 a relatively beta 2 specific agonist, gave a shallow inhibition curve with nH of 0.44.
The most potent antagonist in inhibiting low affinity component. For metoprolol, computer determined high affinity (Ki = 6.8 X lO^M; beta 1 receptor sites) and low affinity (Ki = 7.9 X lO^M; beta 2 receptor sites) sites represented 40 ± 2% and 60 The values are mean ± SEM of three separate experiments in the control group.
Ki for agonists was determined from the equation Ki = ICy/O + S/K D ), where S is the concentration of ^H-DHA used in the assay (15 nM).
Ki for antagonists was determined from nonlinear data analysis program as described in the text. (N = 4) , respectively. The difference between the control and SAH groups was statistically significant. ed 62 ± 5% and 38 ± 5% of 3 H-DHA binding sites, respectively. For butoxamine, computer determined high affinity and low affinity sites represented 29 ± 7% and 71 ± 7% of 3 H-DHA binding sites, respectively. Considering the Bmax value of 3 H-DHA binding site of SAH group (1140 fmol/mg protein), Bmax of beta 1 receptor sites and Bmax of beta 2 receptor sites were calculated 708 ± 57 fmol/mg protein and 482 ± 57 fmol/mg protein, respectively, from the inhibition curve of metoprolol and 810 ± 80 fmol/mg protein and 330 ± 80 fmol/mg protein, respectively, from the inhibition curves of butoxamine ( fig. 5) . Differences between Bmax values of beta 1 receptor sites of the control group and SAH group were significant. But the differences between Bmax values of beta 2 receptor sites were not significant (fig. 5) Pharmacodynamic studies revealed that beta 1 adrenergic receptors mediate vasodilatory effect of isoproterenol in human pial arteries.' The postsynaptic beta adrenergic receptors in the cerebral arteries may be mainly the beta 1 subtype. In other tissues, the presynaptic beta adrenergic receptors were subclassified into beta 2 type.
Inhibition of Specific
23 Although the population of the receptors in presynaptic and postsynaptic sites cannot be determined in binding studies, it is probable that beta 1 adrenergic receptors locate mainly in the postsynaptic sites and beta 2 adrenergic receptors mainly in the presynaptic sites.
We analyzed alterations in beta adrenergic receptors in the cerebral arteries after SAH. K D value of 3 H-DHA binding sites after SAH was not significantly different from values in the control group, whereas the density of 3 H-DHA binding sites was increased after SAH. In addition, the ratio of beta I/beta 2 adrenergic receptors was reversed after SAH. The ratio was 62/38 from the inhibition curve by metoprolol and 71/29 from that by butoxamine. This means that beta 1 adrenergic receptors increase after SAH without significant changes in the number of beta 2 adrenergic receptors. Morphological changes were noted on human cerebral arteries after SAH 24 and in monkey cerebral arteries after experimental SAH. 23 These changes are mainly degenerative ones, including myonecrosis of the media and intimal thickening. When the smooth muscle layer of blood vessels became necrotic and decreased in volume, the receptor sites of the vessel would be relatively increased in appearance, as the receptor density was measured per mg protein of tissue. These morphological changes would explain the increase in 3 H-DHA binding sites after SAH. However, the reversal of the ratio of beta I/beta 2 adrenergic receptors cannot be explained on such basis. It has been reported that cat cerebral arteries became sensitive to catecholamines after sympathetic denervation 26 - 27 and that such supersensitivity was induced by experimental SAH. 27 In a previous study, we demonstrated the increase in number of alpha adrenergic receptors in human cerebral arteries after SAH. 12 Increase of beta 1 adrenergic receptors after SAH in the present study is in line with the previous study. Preganglionic denervation sometimes induced an increase in the number of muscarinic cholinergic receptors in the superior cervical ganglia in cats. 28 The increase of beta 1 adrenergic receptors may also be a denervation effect in the postsynaptic beta adrenergic receptors after SAH. Since beta 1 adrenergic receptors mediate relaxation cerebral arteries and they become sensitive after SAH, the administration of selective beta 1 adrenergic agonists may possibly prevent the occurrence of delayed vasospasms after SAH. 1 The disposition of proteins after SAH may be responsible for the delayed vasospasm. Some investigators have hypothesized that oxyhemoglobin and other proteins from hemolyzed erythrocytes are responsible for or contribute to the vasospasm.^ Fibrin degradation products (FDP) may also play a role because these are reported to produce a contractile response as well as enhance the contractions produced by serotonin or oxyhemoglobin.
5 '
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The serine proteases trypsin, thrombin and plasmin likewise produce vasoconstriction of isolated cerebral arteries." Since fibrinolytic activity peaks many days after the extravasation of blood,
